Table of Contents

2019-2024 Global Cyazofamid Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Cyazofamid Consumption 2014-2024
  • 2.1.2 Cyazofamid Consumption CAGR by Region
• 2.2 Cyazofamid Segment by Type
  • 2.2.1 Type I
  • 2.2.2 Type II
• 2.3 Cyazofamid Consumption by Type
  • 2.3.1 Global Cyazofamid Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Cyazofamid Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Cyazofamid Sale Price by Type (2014-2019)
• 2.4 Cyazofamid Segment by Application
  • 2.4.1 Downy Mildew
  • 2.4.2 Oomycetes Diseases
  • 2.4.3 Others
• 2.5 Cyazofamid Consumption by Application
  • 2.5.1 Global Cyazofamid Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Cyazofamid Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Cyazofamid Sale Price by Application (2014-2019)

3 Global Cyazofamid by Players

• 3.1 Global Cyazofamid Sales Market Share by Players
  • 3.1.1 Global Cyazofamid Sales by Players (2017-2019)
  • 3.1.2 Global Cyazofamid Sales Market Share by Players (2017-2019)
• 3.2 Global Cyazofamid Revenue Market Share by Players
  • 3.2.1 Global Cyazofamid Revenue by Players (2017-2019)
  • 3.2.2 Global Cyazofamid Revenue Market Share by Players (2017-2019)
• 3.3 Global Cyazofamid Sale Price by Players
• 3.4 Global Cyazofamid Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Cyazofamid Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Cyazofamid Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Cyazofamid by Regions

• 4.1 Cyazofamid by Regions
  • 4.1.1 Global Cyazofamid Consumption by Regions
  • 4.1.2 Global Cyazofamid Value by Regions
• 4.2 Americas Cyazofamid Consumption Growth
• 4.3 APAC Cyazofamid Consumption Growth
• 4.4 Europe Cyazofamid Consumption Growth
• 4.5 Middle East & Africa Cyazofamid Consumption Growth

5 Americas

• 5.1 Americas Cyazofamid Consumption by Countries
  • 5.1.1 Americas Cyazofamid Consumption by Countries (2014-2019)
  • 5.1.2 Americas Cyazofamid Value by Countries (2014-2019)
• 5.2 Americas Cyazofamid Consumption by Type
• 5.3 Americas Cyazofamid Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Cyazofamid Consumption by Countries
  • 6.1.1 APAC Cyazofamid Consumption by Countries (2014-2019)
  • 6.1.2 APAC Cyazofamid Value by Countries (2014-2019)
• 6.2 APAC Cyazofamid Consumption by Type
• 6.3 APAC Cyazofamid Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Cyazofamid by Countries
  • 7.1.1 Europe Cyazofamid Consumption by Countries (2014-2019)
  • 7.1.2 Europe Cyazofamid Value by Countries (2014-2019)
• 7.2 Europe Cyazofamid Consumption by Type
• 7.3 Europe Cyazofamid Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Cyazofamid by Countries
  • 8.1.1 Middle East & Africa Cyazofamid Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Cyazofamid Value by Countries (2014-2019)
• 8.2 Middle East & Africa Cyazofamid Consumption by Type
• 8.3 Middle East & Africa Cyazofamid Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Cyazofamid Distributors
• 10.3 Cyazofamid Customer

11 Global Cyazofamid Market Forecast

• 11.1 Global Cyazofamid Consumption Forecast (2019-2024)
• 11.2 Global Cyazofamid Forecast by Regions
  • 11.2.1 Global Cyazofamid Forecast by Regions (2019-2024)
  • 11.2.2 Global Cyazofamid Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Cyazofamid Forecast by Type
• 11.8 Global Cyazofamid Forecast by Application

12 Key Players Analysis

• 12.1 ISHIHARA SANGYO KAISHA
  • 12.1.1 Company Details
  • 12.1.2 Cyazofamid Product Offered
  • 12.1.3 ISHIHARA SANGYO KAISHA Cyazofamid Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 ISHIHARA SANGYO KAISHA News
• 12.2 Rudong Zhongyi
  • 12.2.1 Company Details
  • 12.2.2 Cyazofamid Product Offered
  • 12.2.3 Rudong Zhongyi Cyazofamid Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Rudong Zhongyi News

...

13 Research Findings and Conclusion

Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.
4-methylacetophenone is the main raw materials. Cyazofamid are often applied to treat downy mildew oomycetes diseases.
ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, which production reached 335 MT in 2016, with the share of 81.91%.
The consumption shares of Japan, China, North America and Europe were 42.79%, 21.52%, 17.11% and 11.74%. Japan is the main import region and other countries need to import from Japan.

According to this study, over the next five years the Cyazofamid market will register a 1.6% CAGR in terms of revenue, the global market size will reach US$ 90 million by 2024, from US$ 82 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cyazofamid business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Cyazofamid market by product type, application, key manufacturers and key regions and countries.

This study considers the Cyazofamid value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Type I
Type II
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Downy Mildew
Oomycetes Diseases
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ISHIHARA SANGYO KAISHA
Rudong Zhongyi
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Cyazofamid consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cyazofamid market by identifying its various subsegments.
Focuses on the key global Cyazofamid manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cyazofamid with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cyazofamid submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.